Adhera Therapeutics, Inc.

SIC Pharmaceutical Preparations
Headquarters Wake Forest, NC
Financials
FORMNAMEDATE FILED
10-QQ311/20/2023NT 10-QNotification of inability to timely file Form 10-Q or 10-QSB11/15/202310-QQ28/21/2023NT 10-QNotification of inability to timely file Form 10-Q or 10-QSB8/15/202310-QQ15/22/2023NT 10-QNotification of inability to timely file Form 10-Q or 10-QSB5/15/202310-K/AFY 2022 - amended5/2/2023
Prospectuses and Registrations
FORMNAMEDATE FILED
S-1General form for registration of securities under the Securities Act of 193312/2/2022S-8Securities to be offered to employees in employee benefit plans5/3/2019S-8Securities to be offered to employees in employee benefit plans1/4/2018RWRegistration Withdrawal Request11/22/2017S-1/AGeneral form for registration of securities under the Securities Act of 19338/3/2017S-1/AGeneral form for registration of securities under the Securities Act of 19337/27/2017S-1General form for registration of securities under the Securities Act of 19336/26/2017
Proxies
FORMNAMEDATE FILED
DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material8/18/2022DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material7/6/2022DEF 14AOther definitive proxy statements6/27/2022PRE 14AOther preliminary proxy statements6/17/2022DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material12/13/2019DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material12/6/2019DEF 14AOther definitive proxy statements11/19/2019
News
FORMNAMEDATE FILED
8-KTermination of a Material Definitive Agreement1/18/20248-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers1/16/20248-KEntry into a Material Definitive Agreement11/29/20238-KRegulation FD Disclosure10/12/20238-KEntry into a Material Definitive Agreement6/29/20238-KEntry into a Material Definitive Agreement5/5/20238-KEntry into a Material Definitive Agreement5/4/2023
Ownership
FORMNAMEDATE FILED
3Rice Charles L Jr4/28/20223Waerness Trond Kydd4/21/20223Subhan Zahed11/29/20213Kucharchuk Andrew Albert7/20/20204Stanley Rhonda L.11/5/20193Stanley Rhonda L.11/4/2019SC TO-I/AAdhera Therapeutics, Inc.9/26/2019
Others
FORMNAMEDATE FILED
SEC STAFF ACTIONSEC Staff Action: ORDER1/30/2024DNotice of Exempt Offering of Securities2/19/2020UPLOADSEC-generated letter11/12/2019UPLOADSEC-generated letter10/25/2019UPLOADSEC-generated letter8/23/2019DNotice of Exempt Offering of Securities7/11/2019UPLOADSEC-generated letter6/7/2019